Pitch Introduction
The Sahayatha Shark Tank India pitch stands as one of the most emotional and technologically significant presentations in the history of the show. Founder Sruthi Babu, representing Dhanvantri Biomedical, entered the tank seeking ₹1 Crore for 10% equity. Her innovation, a smart wheelchair designed to restore dignity to immobile patients through an automated cleansing system, immediately captured the attention of the Sharks. The pitch was not just about a product but about solving a deep-seated pain point for 30 million mobility-impaired individuals in India, where nearly 10 million people struggle daily with the basic necessity of using a toilet independently.
Sruthi’s journey, rooted in a personal tragedy and a five-year research cycle alongside her late father, resonated with the investors. Her product aims to reduce the physical and mental burden on both patients and caregivers. With 118 prototypes already developed, Sahayatha represents a fusion of biomedical engineering and deep empathy. The pitch concluded with a rare all-Shark deal, valuing the company at ₹10 Crores, and setting the stage for a revolution in the Indian assistive technology market.
Business Overview
Sahayatha, operated under the banner of Dhanvantri Biomedical Pvt Ltd, is an assistive technology startup based in Coimbatore, Tamil Nadu. The company focuses on enhancing the quality of life for patients suffering from paralysis, Parkinson’s, and other mobility-impairing conditions. Their primary innovation is the Sahayatha Smart Wheelchair, which addresses the “toilet transfer” problem—a major cause of falls and injuries among the elderly and immobile. By integrating a patented cleansing mechanism directly into the chair, the product eliminates the need for multiple caregivers and risky transfers to a commode.
The business model currently operates through a mix of B2B hospital sales and direct-to-consumer e-commerce. In just four months post-launch, the brand managed to place units in various hospitals, which served as a primary validation point. The feedback loop from hospitals leads to individual home orders, creating a natural sales funnel. Furthermore, the company has secured significant government support through grants, showcasing its potential for national-scale impact.
Product Details
The Sahayatha wheelchair is available in two distinct variants: the S100 and the S200. According to YourStory, the S100 model is the premium version priced at ₹39,999, featuring a full 180-degree recline that allows the wheelchair to double as a stretcher. This feature is crucial for patients with zero mobility who need to be shifted from a bed. The S200 model, priced at ₹29,999, is designed for those with partial mobility and does not include the recline feature.
The standout feature of both models is the Smart Defecation Cleansing system. It utilizes a 300 ml water jet spray that cleans the patient’s body after urination or defecation with the simple press of a button. The waste is collected in a detachable bidet module with a 3-liter capacity, capable of being used up to 8 times before needing to be emptied. The entire system is battery-operated, with a seven-hour charge lasting for nearly an entire month of use.
Market Position
Sahayatha occupies a unique niche in the ₹800 Crore Indian wheelchair market. While traditional wheelchairs start as low as ₹5,000, they lack the specialized hygiene features required for immobile patients. Sahayatha’s USP (Unique Selling Proposition) lies in the 90% reduction in falls and transfers and the reduction of required caregivers from three to one. This translates to a massive cost saving for families, as a professional caretaker can cost up to ₹30,000 per month.
| Business Detail | Information |
|---|---|
| Company Name | Sahayatha (Dhanvantri Biomedical) |
| Founder | Sruthi Babu |
| Product Type | Smart Assistive Wheelchair |
| Price Range | ₹29,999 – ₹39,999 |
| Primary Channel | Hospitals, Website, Amazon |
| Headquarters | Coimbatore, Tamil Nadu |
About Founder’s
Sruthi Babu is a Biomedical Engineer who co-founded Dhanvantri Biomedical alongside her father, a mechanical engineer who specialized in mission-critical machinery. The inspiration for Sahayatha came from a hospital visit where Sruthi witnessed an elderly man crying because his two daughters had to assist him with his basic hygiene, leading him to feel like a “burden.” This emotional trigger led to a five-year R&D journey involving 118 prototypes.
Tragically, Sruthi lost her father just months before appearing on Shark Tank India. Despite the immense personal loss, she decided to return to the office within three days to continue their shared mission. Her resilience and technical expertise were highly praised by the Sharks, particularly Amit Jain and Peyush Bansal. You can follow her professional journey on her Founder Profile.
- Educational Background: Biomedical Engineering from Avinashilingam Institute.
- Research History: Conducted 5 years of rigorous research and testing before market launch.
- Grant Funding: Secured ₹1 Lakh from Sparsh Fellowship and ₹50 Lakhs BIG grant from BIRAC.
- Mission: To provide dignity and hygiene to 10 million patients in India needing toilet assistance.
Shark’s and Founder’s QnA
You mentioned that you worked on this with your Dad for 5 years. How did you get involved?
I am a biomedical engineer and my dad was a mechanical engineer. He was a special purpose machinery manufacturer. I always saw him as a hero. We worked together day and night; we didn’t even keep track of time. I lost him recently in January, but I decided I had to get back to work after three days to fulfill our mission.
How much does a normal wheelchair cost compared to Sahayatha?
A normal wheelchair starts from around ₹5,000. But for an immobile patient, you then have to buy a commode wheelchair. After that, you need two caretakers. One caretaker costs around ₹1,000 per day. Our product reduces the need for multiple caretakers and prevents falls, making it much more cost-effective annually.
How do you handle the waste and the cleaning?
There is a spray jet inside that sprays 300 ml of water to wash the body completely after urination or defecation. It is battery operated. The waste and water are collected in a 3-liter can that can be washed easily. It can be used eight times before needing a refill/empty cycle.
Is the product patented?
Yes, it is a patented product. We have filed an Indian patent, a PCT covering 140 countries, and US patents. It is currently in the final stages of being granted.
What are your sales figures so far?
In the four months since we launched, we have sold nearly 12 devices. 10 of these were sold directly to hospitals. Once hospitals use them, families often place orders for home use. We also have a pipeline of orders from state and central governments.
How large is the wheelchair market in India?
The wheelchair market in India is currently estimated at ₹800 Crores. While it might seem small compared to global standards, we see a huge potential for international expansion, which is why we filed for global patents.
₹40,000 is high for low-income groups. How will you solve this?
We want to introduce a financing model. We have already tied up with Bajaj Finserv. Over time, as we scale production, we aim to bring the price down to match that of a normal wheelchair.
Key Stats & Financials
At the time of the Sahayatha Shark Tank India pitch, the business was in its early commercialization phase. Having launched just four months prior, the focus was on clinical validation and pilot sales rather than massive revenue numbers. The company had already demonstrated financial viability through significant non-dilutive funding, including a ₹50 Lakhs grant from BIRAC (Biotechnology Industry Research Assistance Council).
Revenue and Profitability
- Total Units Sold: 12 devices (in 4 months post-launch).
- Grant Funding: ₹51 Lakhs (cumulative from various government bodies).
- Valuation: ₹10 Crores (based on the Shark Tank deal).
- Investment Request: ₹1 Crore for 10% equity.
- Pricing: ₹29,999 (V200) to ₹39,999 (S100).
Financial Breakdown
| Metric | Amount / Value |
|---|---|
| Initial Grant (Sparsh) | ₹1 Lakh |
| BIG Grant (BIRAC) | ₹50 Lakhs |
| Unit Price (Premium) | ₹39,999 | ₹29,999 |
| Battery Life | 30 Days per charge |
| Water Capacity | 3 Liters |
Business Potential and TAM
The business potential for Sahayatha is immense, given the aging population in India and globally. The Total Addressable Market (TAM) for assistive devices is expanding rapidly as healthcare infrastructure improves and the demand for “aging in place” solutions grows. The global wheelchair market was valued at approximately $5 Billion (₹42,000 Crores) in 2022 and is projected to grow at a CAGR of 7%.
In India specifically, there are 30 million people with mobility issues. The segment that specifically needs toilet assistance represents about 10 million individuals. This creates a focused market opportunity of several thousand crores for specialized wheelchairs like Sahayatha. By providing a solution that prevents the 4% annual mortality rate associated with toilet transfer falls, Sahayatha isn’t just selling a product; they are offering a life-saving medical device.
Market Size Analysis
The Indian wheelchair market size of ₹800 Crores is currently dominated by basic, low-cost models imported from China. However, Sahayatha targets the premium medical-grade segment, which is currently underserved. As medical insurance starts covering assistive devices and government schemes like ADIP (Assistance to Disabled Persons) expand, the market for localized, high-tech wheelchairs is expected to triple by 2030. The global expansion potential into the 140 countries covered by their PCT filing further multiplies their TAM by 10x.
Growth Opportunities
- Global Export: Leveraging the US and international patents to enter high-spending medical markets in the West.
- Rental Model: Implementing a subscription or rental model for patients in short-term recovery.
- Government Contracts: Securing bulk orders through the Ministry of Social Justice and Empowerment.
- B2B Hospital Integration: Making Sahayatha a standard equipment in geriatric and ICU wards nationwide.
Sahayatha: Ideal Target Audience & Demographics
| Demographic | Details |
|---|---|
| Primary Age Group | 65+ years (Geriatric care) |
| Secondary Age Group | 25-50 years (Post-accident/trauma) |
| Interests | Home Healthcare, Elder Care, Rehabilitation |
| Platform Preference | Facebook, WhatsApp, LinkedIn (Doctors) |
| Geography | Tier 1 and Tier 2 cities in India |
| Buying Behavior | Problem-solving led, high trust requirement |
Marketing and Distribution Strategy
Sahayatha’s marketing strategy is heavily reliant on trust and validation. In the medical device industry, patients rarely buy products based on flashy advertisements; they rely on recommendations from healthcare professionals. Thus, Sahayatha focuses on clinical validation and presence in major hospitals to build a credible brand image from the ground up.
Customer Acquisition
The company acquires customers through hospital touchpoints. When a patient is discharged, the hospital staff or physical therapists often recommend the chair as a home-care solution. Additionally, the founder mentioned using WhatsApp and their official website for direct orders, allowing them to maintain higher margins compared to third-party marketplaces. The CAC is relatively low as the product solves a high-intent problem where customers are actively searching for solutions.
Distribution Channels
- Hospital B2B: Direct supply to rehabilitation centers and multi-specialty hospitals.
- D2C E-commerce: Sales through the official Sahayatha website and WhatsApp Business.
- Online Marketplaces: Presence on Amazon and Flipkart for wider national reach.
- Financing Partners: Tie-up with Bajaj Finserv to make the ₹30k-40k price point accessible.
Social Media and Content Strategy
The brand utilizes video demonstrations on YouTube and Facebook to show the product’s functionality. Since the “cleansing” aspect is hard to explain via text, high-quality demo videos are essential. Their content strategy focuses on the emotional benefit of dignity and the practical benefit of fall prevention, targeting the adult children of elderly parents who are the primary decision-makers.
Sahayatha Shark Tank Deal Outcome
The negotiation for Sahayatha was one of the smoothest in Season 2. Amit Jain was the first to offer exactly what the founder asked for: ₹1 Crore for 10% equity. He was quickly joined by Namita Thapar, who offered her expertise in hospital networks. Soon, Peyush Bansal, Anupam Mittal, and Aman Gupta all expressed interest in joining the deal.
| Shark | Offer Detail |
|---|---|
| Amit Jain | Joined all-Shark offer (₹20 Lakhs for 2%) |
| Namita Thapar | Joined all-Shark offer (₹20 Lakhs for 2%) |
| Peyush Bansal | Joined all-Shark offer (₹20 Lakhs for 2%) |
| Anupam Mittal | Joined all-Shark offer (₹20 Lakhs for 2%) |
| Aman Gupta | Joined all-Shark offer (₹20 Lakhs for 2%) |
| Final Decision | Accepted ₹1 Crore for 10% equity from all five Sharks |
Sahayatha Post-Show Update
Following the appearance on Shark Tank India, Sahayatha witnessed a massive surge in demand. According to Inc42, Namita Thapar successfully closed the deal and remains an active mentor for the company. The exposure helped the brand secure additional government interests and expanded its footprint into more hospitals across South India. Sruthi Babu’s story was widely celebrated in the media as a prime example of successful women-led biomedical innovation in India.
Revenue figures and specific unit sales post-show are currently being scaled. The brand has been actively working on optimizing its manufacturing processes to meet the influx of orders from individual buyers who saw the pitch. The company is also exploring the international markets as planned during the pitch.
Business Analysis & Lessons
The success of Sahayatha highlights the importance of purpose-driven engineering. While many startups focus on entertainment or luxury, Sahayatha addressed a fundamental human need—dignity. The business model is robust because it doesn’t just sell a product; it sells a solution that significantly reduces the recurring cost of caregiving. By proving the product in hospitals before approaching individual consumers, Sruthi built a moat of clinical credibility that is difficult for generic competitors to replicate.
For entrepreneurs, the Sahayatha pitch is a lesson in persistence and technical depth. Spending five years and building 118 prototypes ensures that the final product is reliable—a non-negotiable factor in the medical industry. Sruthi’s ability to channel her personal grief into a mission for millions demonstrated a high level of founder-market fit, which is one of the most important criteria for Shark investment.
Key Takeaways
- Lesson 1: Credibility over Marketing. In medical tech, pilot testing in hospitals is more valuable than any social media ad campaign.
- Lesson 2: Patent Protection. Filing global patents early protected their 5-year R&D and paved the way for international licensing.
- Lesson 3: Solving Emotional Pain. The best products solve a functional problem (mobility) and an emotional one (dignity).
- Lesson 4: Resilience. The Sharks didn’t just invest in the wheelchair; they invested in a founder who could lead through extreme personal adversity.
Pitch Conclusion
The Sahayatha pitch remains a gold standard for social impact startups on Shark Tank India. With a ₹1 Crore five-shark deal, Sruthi Babu secured more than just capital; she gained the combined mentorship of India’s top business minds to take her father’s legacy global. As the company continues to scale, it serves as a beacon of hope for the millions seeking independence in their daily lives. If you enjoyed this breakdown, check out MeduLance, DigiQure, and Pharmallama.
[faq_accordian]